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A B S T R A C T
Differentiation between benign and malignant biliary strictures is critical to the provision of adequate treatment.
Brush cytology during the endoscopic retrograde cholangiopancreatography (ERCP) is the most commonly used method
for obtaining tissue confirmation of the nature of biliary strictures. It’s specificity is remarkably high but reported sensi-
tivities for the diagnosis of malignancy are low. Aim of our study was to assess sensitivity and specificity of biliary brush
cytology in our institution, to find out main causes of false negative diagnoses and to confirm impression that the team
approach has impact on sensitivity. Gold standard for diagnosis was definitive surgical histology or adequate clinical
follow up for minimum of six month. Direct smears made by cytotechnician at the endoscopy room, and stained accord-
ing to Papanicolaou and May-Grünwald Giemsa (MGG) were examined for well-recognized features of malignancy on
conventional smears as a part of diagnostic routine. Cytologic diagnoses were benign, atypical/reactive, suspicious for
malignancy and malignant. Of 143 brushings with available definitive diagnosis 36 (25%) had malignant cytologic di-
agnosis and 91(63.6%) were classified as benign, 3 were atypical/reactive and 13 suspicious for malignancy with 20
»false-negative« cases. When specimens with atypical and suspicious cytology were excluded from data analysis sensitiv-
ity was 64% and specificity was 100% and when suspicious findings were taken into account as true positives sensitivity
rose to 71%. We find that biliary brush cytology, although mainly depending on the skill of endoscopist, as well as the ex-
perience of the cytologist, is a valuable method for obtaining accurate tissue diagnosis of biliary strictures, thus solving
eternal diagnostic dilemma: benign or malignant.
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Introduction
Malignant biliary strictures can be difficult to distin-
guish from benign conditions during endoscopy and de-
spite new diagnostic tools preoperative diagnosis of
biliary strictures remains a challenge1–3. Accurate differ-
entiation between benign and malignant processes is
critical to the provision of adequate treatment, so the im-
portance of tissue based diagnosis of biliary strictures is
well recognized4. The differential diagnosis includes but
is not limited to: primary sclerosing cholangitis, gallblad-
der carcinoma, pancreatic carcinoma, intraductal papil-
lary mucinous tumor or benign postimmflamatory stric-
tures. Majority of pancreatobiliary malignant neoplasms
are carcinomas but other malignant tumors can be en-
countered.
Brush cytology during the endoscopic retrograde cho-
langiopancreatography (ERCP) is most commonly used
method for obtaining tissue confirmation of the nature of
biliary strictures. Since its introduction5 many studies
have shown that brush cytology during ERCP is useful
diagnostic method which is simple to perform, does not
increase rate of complications and has potential of ob-
taining definitive diagnosis, aiding in further patient
management. Its specificity is remarkably high but the
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main complaint about the method is its low sensitivity
for the diagnosis of malignancy. Most of the studies re-
port sensitivity 30–54% for bile duct brushings and
26–88% for overall brushings of pancreatobiliary tract6.
Low sensitivity is commonly attributed to the high rate
of false negative diagnosis. Sampling errors and techni-
cal reasons such as air-drying artifacts have been re-
ported as main reasons for high rate of false negatives7.
Better communication and team approach are said to
have impact on sensitivity also8. Kocjan et al. found four
main categories of reasons responsible for low sensitivity
of biliary brushings including sampling error, dysplasia,
special tumor types and smear background9.
Aim of our study was to assess sensitivity and specific-
ity of biliary brush cytology in our institution. Reviewing
false negative cases we wanted to identify main causes of
false negative diagnoses and tried to recognize which of
mentioned factors influenced cytologic diagnosis the
most. We also wanted to confirm impression that the
team approach has impact on sensitivity as reported.
Material and Methods
During the five years period (between November 2003
and December 2008) 201 brushings from 178 patients
with lesion of the pancreato-biliary system, including pa-
pilla, were taken during the ERCP procedure and sub-
mitted to our cytology department. For the purpose of
this study only patients with definitive diagnosis were
considered. Inadequate samples, 3 of them, were also ex-
cluded from analysis. Gold standard for diagnosis was de-
finitive surgical histology or adequate clinical follow up
for minimum of six month. Follow up was not possible for
some patients referred from other institutions for ERCP
procedure alone, but for 143 samples complete data were
available.
Sample collection and smear preparation
Depending on the amount of collected material, for
each patient 2–5 direct smears were made by cytotechni-
cian present at the endoscopy room. At least one smear
was immediately fixed in 95% ethanol for Papanicolaou
staining and the rest were air-dried and subsequently
stained according to May-Grünwald Giemsa (MGG). In
rare cases immunocytochemistry was performed.
Specimens were examined for well-recognized fea-
tures of malignancy on conventional smears as a part of
diagnostic routine. Considering well-established criteria,
cytologic diagnoses were categorized as benign, atypical/
reactive, suspicious for malignancy and malignant9–15.
Statistical analysis was performed using MedCalc for
Windows, version 10 (MedCalc Software, Mariakerke,
Belgium).
Results
From a total of 201 biliary brushings gold standard di-
agnosis was obtained for 143 specimens from 119 pa-
tients. There were 34 females and 85 males, mean age
was 62 years (range 20–89).
Of 143 brushings with available definitive diagnosis
36 (25%) had malignant cytologic diagnosis and 91 (63.6%)
were classified as benign. However, 20 out of 91 patients
with initially benign cytologic diagnosis had subsequent
malignant diagnosis established either by FNA, surgical
specimen or clinical course, so they were considered as
false negatives (Table 1). Main malignant diagnosis was
carcinoma (Figure 1) and there was one case of lym-
phoma (Figure 2) and one metastatic melanoma found in
brushing specimens. Twelve patients had repeated pro-
cedures in the course of several months and ten of them
remained negative for malignancy. Two cases diagnosed
as malignant in repeated cytology, had initially less than
satisfactory specimens and were repeated immediately
after negative diagnosis. There were 3 cases (2%) diag-
nosed as atypical/reactive and 13 (9%) specimens were
suspicious for malignancy.
When cases with cytologic diagnosis of atypia and sus-
picious for malignancy were excluded from data analysis
(leaving 127 specimens), absolute sensitivity was 64%
and specificity was 100%. Of thirteen suspicious diagno-
ses, 12 had hystological diagnosis of carcinoma on subse-
quent surgery and one case was diagnosed as dysplasia
gravis on biopsy specimen. For this study this case was
considered false positive. All atypical cases were shown
to be benign on follow up (Table 1). When thirteen suspi-
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TABLE 1
CYTOLOGIC AND DEFINITIVE DIAGNOSIS IN 143 BILIARY
BRUSH SPECIMENS
Definitive diagnosis
Cytology Benign Malignant Total
Benign 71 20 91
Atypical 3 0 3
Suspicious 1 12 13
Malignant 0 36 36
Total 75 68 143
Fig. 1. Group of clearly malignant cells,sufficient for diagnosis
of carcinoma (Papanicolaou stain, x1000).
cious cases were combined with cases positive for malig-
nancy into a single category, as is customary, sensitivity
rose to 71% and specificity dropped to 98.7%. Carefully
reviewing 20 false negative cases, we found malignant
cells present on the slides in only one case.
Discussion and Conclusion
Most of the studies report sensitivity of only 30–54%
for bile duct brushings and 26–88% for overall brushings
of pancreatobiliary tract6,11,16. Although those results are
not directly comparable due to the fact that some of them
refer to specific pathology (high sensitivity being re-
ported for detection of cholangiocarcinoma in the special
setting of primary slerosing cholangitis10) and different
use of statistical tests6,17,18, their common denominator is
relatively low sensitivity7,19–22. Reasons for low sensitiv-
ity have been discussed6, and according to Kocjan et al.
they fall into several categories including sampling error,
dysplasia, special tumor types and smear background.
We don’t regularly use the term dysplasia in our labora-
tory, and the term suspicious is reserved for specimens
that meet some criteria for malignancy but we were not
confident to make definitive diagnosis, usually due to
poor preservation of cells or low number of undoubtedly
malignant cells on the slide.
Absolute sensitivity of biliary brush cytology (exclud-
ing suspicious and atypical findings from data analysis)
in our institution was 64%, somewhat higher than in
most reported studies. With suspicious findings included
in malignant category, sensitivity rose to 71% with only a
minimal drop of specificity. Urbano and his group showed
that the team work and close cooperation of cytopatho-
logist and gastroenterologist have an impact on sensitiv-
ity of the method. In our institution cytotechnician is al-
ways present in the endoscopy room at the time of the
procedure, smears are made directly on the glass slides
and relevant clinical informations are obtained. We be-
lieve that this kind of preparation of cytologic material
has positively influenced sensitivity of the method and is
probably the reason for low proportion of inadequate
smears (1%) due to scant cellularity7,12. Immediate etha-
nol fixation and air-drying of the rest of the slides enabled
us to minimize impact of technical errors and air-drying
artifacts on cytologic interpretation which some authors
find to be important reason for false negative diagnoses7.
We prefer to use two different methods of staining for
evaluation of biliary brush specimens. Each staining has
its advantages. Nuclear details are better appreciated on
Papanicolaou stained smears but MGG staining lessen
the impact of air-drying artifacts. The importance of clini-
cal information and its impact on cytologic diagnosis has
been documented on several occasions8,9,17.
Greatest impact on biliary brushings sensitivity had a
fact that 20 out of 143 (14%) brushings that had benign
cytology were found to be malignant by other diagnostic
methods or final clinical diagnosis. We reviewed all cases
of false negative diagnosis and found that in this group
most smears were not representative of the lesion, be-
cause the brush did not reach the malignant lesion.
There was only one true false-negative where we initially
missed malignant cells on the slides. On revision we
found one cluster of malignant cells that was overlooked
amongst clusters of otherwise atypical but reactive look-
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Fig. 2. Non-Hodgkin lymphoma in biliary brushing specimen
(MGG stain, x1000).
Fig. 3. Normal bile duct brushings a) group of benign epithelial
cells; b) benign spindle cells (after sphincterotomy) (Papanicolaou
stain, x1000).
ing epithelium. All other specimens had no malignant
cells on slides even when careful searching was con-
ducted, so we concluded that sampling was the most im-
portant factor that influenced cytological diagnosis. This
finding is in agreement with most studies dealing with
biliary brush cytology. It is worth mentioning that among
those 20 cases there were 4 cases of gallbladder carci-
noma, 11 cases of pancreatic cancer, only two cholangio-
carcinoma of common bile duct and one primary site re-
mained unknown but was presumably of pancreatobiliary
origin. Two cases of ampullary carcinoma remained un-
diagnosed by cytology. With the exception of ampullary
carcinoma, all other lesions were not easy to reach dur-
ing the ERCP, but were diagnosed by other means includ-
ing EUS guided FNA.
Excluding suspicious findings from analysis, there
were no false-positive cases in this series, so our results
for specificity were high as expected. One case classified
as suspicious had diagnosis of high grade dysplasia on bi-
opsy specimen from the papilla and when encountered in
statistical analysis it caused the drop of specificity to
98.7%. Regarding other tumor types, cytology recognized
and subsequently proved by immunocytochemistry one
case of malignant melanoma metastatic to pancreas with
malignant cells found in brushings, and there was also
one case of non-Hodgkin lymphoma found. Accurate di-
agnosis had certainly influenced clinical management of
those patients. We encountered two cases suspicious for
mucinous neoplasm, probably malignant, but since both
patients were from other institutions we were not able to
trace relevant data regarding clinical follow up, so these
cases were excluded from analysis. Cytologist interpreta-
ting brushing specimens should be familiar with cells
types that are normally found in this type of material
(Figures 3a and b) as well as with changes encountered
due to technical reasons and reactive changes. Interpre-
tation of inflammatory and reactive epithelial changes is
always difficult, especially when atypical cells are but a
few on the slide17,23. Number of benign conditions includ-
ing inflammatory disorders, presence of stones, or stent
placement may cause severe nuclear and sometimes ar-
chitectural changes making it difficult to distinguish
from malignant cells (Figures 4 and 5), thus raising a
possibility of making false positive diagnosis. Sticking to
the established diagnostic criteria9,14 and refraining of
making the diagnosis on technically less than satisfac-
tory slides should lessen although would not completely
solve the problem24,25.
Number of ancillary techniques were evaluated in an
attempt to achieve better sensitivity of biliary brush
specimens for diagnosis of malignancy, including fluores-
cence in situ hybridization (FISH), digital image analysis
(DIA) and molecular mutational studies26–28. Although
they claim to increase diagnostic sensitivity, these meth-
ods are fairly expansive, need abundant material to be
performed and are quite technically complex17,18, so their
introducing in routine practice is not only difficult at the
moment19 but perhaps also unnecessary. We find that
biliary brush cytology, although mainly depending on the
skill of endoscopist, as well as the experience of the cytol-
ogist, is a valuable method for obtaining accurate tissue
diagnosis of biliary strictures thus solving eternal diag-
nostic dilemma: benign or malignant.
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Fig. 4. Reactive changes (Papanicolaou stain, x1000).
Fig. 5. Malignant cells (Papanicolaou stain, x1000).
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CITOLO[KI RAZMAZI BRISA ^ETKICOM U DIJAGNOSTICI MALIGNIH PROMJENA BILIJARNOG
STABLA: NA[E ISKUSTVO
S A @ E T A K
Preoperativno razlikovanje malignih od benignih su`enja bilijarnog stabla usprkos novim dijagnosti~kim mogu}no-
stima jo{ uvijek predstavlja izazov, a va`nost tkivne dijagnoze je neupitna za izbor odgovaraju}eg postupka lije~enja.
Razmaz brisa ~etkicom pri endoskopskoj retrogradnoj kolangiopankreatografiji (ERCP) i citolo{ka analiza uzorka je
danas uobi~ajena metoda za dobivanje tkivne dijagnoze. Dosada{nje studije su pokazale da je metoda visoko specifi~na
ali uglavnom slabo osjetljiva zbog velikog broja la`no negativnih citolo{kih dijagnoza. Cilj ovog rada je bio provjeriti
osjetljivost i specifi~nost metode u na{oj ustanovi, prona}i glavne uzroke la`no negativnih citolo{kih nalaza te potvrditi
utjecaj timskog pristupa na citolo{ku dijagnozu. Zlatni standard za dijagnozu bio je histolo{ki nalaz ili klini~ki ishod
utvr|en pra}enjem najmanje {est mjeseci. Svi su razmazi napravljeni metodom direktnog nano{nja materijala sa ~etkice
na staklo odmah po uzimanju uzorka u sobi za endoskopiju uz prisustvo citotehni~ara. Dio razmaza je odmah fiksiran u
etanolu i bojan po Papanicolaou a dio su{en na zraku i bojan metodom po May-Grünwald Giemsi (MGG). Razmazi su
rutinski analizirani i ocijenjeni kao benigni, atipi~ni/reaktivni, suspektni i maligni. Od 143 uzorka s poznatim kona-
~nim ishodom njih 36 (25%) je citolo{ki ocijenjeno malignim, 91 (63.6%) uzorak je bio benigan, uz 3 atipi~na i 13 sus-
pektnih. Kona~na maligna dijagnoza je postavljena u 20 od 91 citolo{ki benignog uzorka. Islju~iv{i uzorke s atipi~nim i
suspektnim citolo{kim nalazom iz analize, osjetljivost metode iznosi 64% uz uobi~ajeno visoku specifi~nost od 100%.
Staviv{i suspektne i pozitivne citolo{ke nalaze u jednu kategoriju kako je uobi~ajeno, osjetljivost je narasla na 71%. Iako
ovisi vje{tini endoskopi~ara i iskustvu citologa mo`emo slobodno zaklju~iti da je citolo{ka analiza razmaza brisa ~et-
kicom pri ERCP-u vrijedna metoda za dobivanje pouzdane tkivne dijagnoze.
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